Sbir phase II: anti-tumor immune redirectors (airs) for cancer treatment

Ended Project Grant Awarded Last action

Award ID
1950998
Recipient
Awarding agency
Obligated
$1,355,844

Award facts

Assistance listing
47.084 NSF Technology, Innovation, and Partnerships
Completion date
Originally
Place of performance
Baltimore, MD 21205, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $500,000
Amendment $0
Amendment $0
Amendment $134,306
Amendment $50,000
Original award $671,538

Quick answers

Who received award 1950998?

1950998 was awarded to Verimmune Inc. by National Science Foundation on May 1, 2020.

How much is award 1950998 worth?

$1,355,844 has been obligated on 1950998.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award